Overview Alkaptonuria (AKU) is a rare inherited metabolic disorder caused by mutations in the HGD (Homogentisate 1,2-Dioxygenase) gene. These mutations reduce or eliminate the activity of the HGD enzyme, leading to the accumulation of homogentisic acid (HGA) in the body. Excess HGA can cause dark-colored urine, pigmentation of connective tissues (ochronosis), joint damage, and other long-term complications.
What is HGD Gene Analysis?
HGD Gene Analysis is a molecular genetic test that detects disease-causing variants in the HGD gene to confirm or rule out Alkaptonuria.
Who Should Consider This Test?
Individuals with dark urine since infancy or childhood
People with suspected Alkaptonuria symptoms
Patients with unexplained early-onset arthritis or ochronosis
Family members of affected individuals
Couples with a family history of Alkaptonuria seeking carrier screening
Symptoms of Alkaptonuria
Urine that darkens on standing
Bluish-black pigmentation of ears, eyes, and skin
Joint pain and stiffness
Early degenerative arthritis
Kidney or prostate stones
Heart valve calcification in later life
Benefits of the Test
Confirms the genetic cause of Alkaptonuria
Supports accurate diagnosis and clinical management
Identifies carriers within families
Enables genetic counseling and family planning
Assists in early monitoring to reduce complications
Sample Required
Peripheral Blood (EDTA)
Method
Next-Generation Sequencing (NGS) with confirmatory analysis when required
Ideal For
Children and adults with suspected Alkaptonuria
Individuals with elevated homogentisic acid levels
Families with known HGD gene mutations
Why Choose This Test?
Early genetic diagnosis helps guide medical care, monitor disease progression, identify at-risk family members, and support informed reproductive decisions.
Note: This test should be interpreted alongside clinical findings, biochemical investigations, and genetic counseling for comprehensive diagnosis and management.